Henry Schein, Inc.
Health
Performance
3.7
Risk
Sell
Buy
Curious about the Scores? Learn more.

Henry Schein, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

24.01.2026
On shaky ground. Struggling to find a clear direction.
24.01.2026
Momentum tanked. Clearly underperforming.
04.11.2025
Calmer waters ahead. Risk signals cooling off.
20.08.2025
Climbing out. Risks fading, but not out of the woods.

Henry Schein, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Henry Schein, Inc. do? Business model and key facts

Get the full picture of Henry Schein, Inc.: what it builds, where it operates, and how it makes money.

Henry Schein, Inc. Profile

Sector: Healthcare

Industry: Medical - Distribution

Employees (FY): 25000

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

shop
Company facts
Stanley Bergman
CEO
25000
Employees worldwide
shop
Performance
0.23%
Last 12 months
12.76%
Last 5 years
shop
Growth
$12,67B
Revenue year
$398,00M
Net income
shop
Valuation
$9,32B
Market Cap
22.89
Price/Earnings Ratio

Stocks related to Henry Schein, Inc.

Selected based on industry alignment and relative market positioning.

CAH
Cardinal Health, Inc.
214.04
+1.47%
3.8
Sell
Buy
Cardinal Health, Inc.
COR
Low-poly 3D Cencora (COR) stock icon with a stylized medical cross, symbolizing healthcare and biotech.
356.14
+0.18%
3.2
Sell
Buy
Cencora, Inc.
MCK
Low-poly 3D McKesson (MCK) stock icon with a stylized delivery box, symbolizing e-commerce and logistics.
834.18
+0.91%
2.7
Sell
Buy
McKesson Corporation
PBH
Prestige Consumer Healthcare Inc.
63.90
-2.68%
3.8
Sell
Buy
Prestige Consumer Healthcare Inc.
GRDN
Guardian Pharmacy Services, Inc.
29.71
-3.07%
7.3
Sell
Buy
Guardian Pharmacy Services, Inc.

Henry Schein, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.